更新
5月22日 - ** Vigil Neuroscience
** 如果涨势得以保持，该股将创下历史上最好的一天
** 赛诺菲将向Vigil股东支付每股8美元，股东还将有资格获得每股2美元的或有价值权$(CVR)$
** 经纪公司 Leerink Partner 称，此次收购符合赛诺菲 "强调将螺栓并购作为资本分配优先事项 "的理念。
** CVR 与 Vigil 正在开发的一种可能治疗阿尔茨海默病的药物有关
** 去年， (link) ，赛诺菲
** 券商预计，"根据最近大市值公司的季度业绩电话评论"，SMID市值制药公司的并购将加速
** 包括盘中走势在内，该股今年累计涨幅超过四倍
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.